Idebenone: all 25 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke EpilepsyRecruitingNCT05987397Phase 4
• Idebenone for the Preventive Treatment of MigraineRecruitingNCT04151472Phase 3
• Study of Oral Idebenone to Treat Non-Alcoholic SteatohepatitisCompletedNCT04669158Phase 1/2Results posted
• Study to Assess the Efficacy and Safety of Raxone in LHON PatientsCompletedNCT02774005Phase 4Results posted
• Idebenone for Primary Progressive Multiple SclerosisCompletedNCT01854359Phase 1/2Results posted
• Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)CompletedNCT01303406Phase 3Results posted
• Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)CompletedNCT01027884Phase 3Results posted
• Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)CompletedNCT00993967Phase 3Results posted
• Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)CompletedNCT00950248Phase 1/2Results posted
• A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) PatientsCompletedNCT00905268Phase 3Results posted
• Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like EpisodesCompletedNCT00887562Phase 2Results posted
• Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia PatientsCompletedNCT00697073Phase 3Results posted
• Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular DystrophyCompletedNCT00654784Phase 2Results posted
• Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's AtaxiaCompletedNCT00537680Phase 3Results posted
• Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine PatientsStatus unknownNCT05411978Phase 4
• A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into SynucleinopathiesActive, not recruitingNCT04534023Phase 2
• A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson DiseaseWithdrawnNCT04152655Phase 2/3
• Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)TerminatedNCT03603288Phase 3
• A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid SteroidsTerminatedNCT02814019Phase 3
• Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)WithdrawnNCT01495715Phase 3
• Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)CompletedNCT00758225Phase 2
• Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic NeuropathyCompletedNCT00747487Phase 2
• Idebenone to Treat Friedreich's AtaxiaCompletedNCT00229632Phase 2
• Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaCompletedNCT00078481Phase 1
• Safety Study of Idebenone to Treat Friedreich's AtaxiaCompletedNCT00015808Phase 1

← Idebenone overview